171 related articles for article (PubMed ID: 8781418)
41. Regulation of megakaryocytopoiesis by thrombopoietin.
McDonald TP
Ann N Y Acad Sci; 1987; 509():1-24. PubMed ID: 3322129
[TBL] [Abstract][Full Text] [Related]
42. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
43. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells.
Williams JL; Pipia GG; Datta NS; Long MW
Blood; 1998 Jun; 91(11):4118-26. PubMed ID: 9596657
[TBL] [Abstract][Full Text] [Related]
44. Thrombopoietin (Mpl-ligand) and the regulation of platelet production.
Cohen-Solal K; Debili N; Vainchenker W; Wendling F
Thromb Haemost; 1997 Jul; 78(1):37-41. PubMed ID: 9198124
[TBL] [Abstract][Full Text] [Related]
45. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
46. The effects of Mpl-ligand, interleukin-6 and interleukin-11 on megakaryocyte and platelet alpha-granule proteins.
Philipp CS; Remmler J; Zucker-Franklin D
Thromb Haemost; 1998 Dec; 80(6):968-75. PubMed ID: 9869169
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
[TBL] [Abstract][Full Text] [Related]
48. Clinical findings with the first generation of thrombopoietic agents.
Vadhan-Raj S
Semin Hematol; 2010 Jul; 47(3):249-57. PubMed ID: 20620436
[TBL] [Abstract][Full Text] [Related]
49. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation.
Nagahisa H; Nagata Y; Ohnuki T; Osada M; Nagasawa T; Abe T; Todokoro K
Blood; 1996 Feb; 87(4):1309-16. PubMed ID: 8608219
[TBL] [Abstract][Full Text] [Related]
50. Effects of recombinant thrombopoietin on the growth of murine primitive and committed hematopoietic progenitors in serum-free culture.
Sasaki H; Ikuta K; Funabiki T; Fujioka K; Matsuda M
Pediatr Int; 1999 Dec; 41(6):666-72. PubMed ID: 10618888
[TBL] [Abstract][Full Text] [Related]
51. Effects of cytokines on platelet production from blood and marrow CD34+ cells.
Norol F; Vitrat N; Cramer E; Guichard J; Burstein SA; Vainchenker W; Debili N
Blood; 1998 Feb; 91(3):830-43. PubMed ID: 9446643
[TBL] [Abstract][Full Text] [Related]
52. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
[TBL] [Abstract][Full Text] [Related]
53. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK).
Hodohara K; Fujii N; Yamamoto N; Kaushansky K
Blood; 2000 Feb; 95(3):769-75. PubMed ID: 10648384
[TBL] [Abstract][Full Text] [Related]
54. Megakaryothrombopoiesis during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin.
Woo SY; Kie JH; Ryu KH; Moon HS; Chung WS; Hwang DH; Kim SK; Han TH; Hahn MJ; Chong YH; Park HK; Seoh JY
Scand J Immunol; 2002 Jan; 55(1):88-95. PubMed ID: 11841696
[TBL] [Abstract][Full Text] [Related]
55. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
Proulx C; Boyer L; Hurnanen DR; Lemieux R
J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
[TBL] [Abstract][Full Text] [Related]
56. Thrombopoietin: understanding and manipulating platelet production.
Kaushansky K
Annu Rev Med; 1997; 48():1-11. PubMed ID: 9046940
[TBL] [Abstract][Full Text] [Related]
57. Thrombopoietin-independent effect of interferon-gamma on the proliferation of human megakaryocyte progenitors.
Muraoka K; Tsuji K; Yoshida M; Ebihara Y; Yamada K; Sui X; Tanaka R; Nakahata T
Br J Haematol; 1997 Aug; 98(2):265-73. PubMed ID: 9266918
[TBL] [Abstract][Full Text] [Related]
58. Effects of thrombocytopoiesis-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes.
Straneva JE; Briddell RA; McDonald TP; Yang HH; Hoffman R
Exp Hematol; 1989 Dec; 17(11):1122-7. PubMed ID: 2684680
[TBL] [Abstract][Full Text] [Related]
59. Quantitative and qualitative differences in thrombopoietin-dependent hematopoietic progenitor development between cord blood and bone marrow.
Mwamtemi HH; Higuchi T; Sawai N; Hidaka E; Koike K
Transplantation; 2000 Apr; 69(8):1645-54. PubMed ID: 10836376
[TBL] [Abstract][Full Text] [Related]
60. 2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate enhances thrombopoietin-induced megakaryocytic differentiation and plateletogenesis.
Kim J; Jin G; Lee J; Lee K; Bae YS; Kim J
BMB Rep; 2019 Jul; 52(7):434-438. PubMed ID: 30670147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
